Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2023-05-22 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 22.05.2023 from ZIM LABORATORIES LIMITED addressed to stock exchanges, informing about the availability of the audio recording of the Q4 and FY 23 Earnings Conference Call on the company's website. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure requirements. The document does not contain any financial data or detailed transcript but merely announces the availability of the earnings call recording. The document length is 2116 characters, which is short and fits the pattern of an announcement rather than the full transcript or report. According to the classification rules, announcements about availability of earnings call recordings or transcripts are best classified as Regulatory Filings (RNS) because they do not contain the full transcript or substantive financial data themselves.
2023-05-22 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) regarding the publication of financial results for the quarter and year ended 31.03.2023. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates newspaper publication of financial results. The document includes a cover letter and copies of newspaper publications of the financial results. It does not contain the full financial statements or detailed financial analysis itself but rather serves as an intimation or announcement that the financial results have been published in newspapers. The document length is about 15,000 characters, but the content is primarily an announcement of publication rather than the full financial report. According to the "Menu vs Meal" rule, such documents are classified as Report Publication Announcement (RPA) rather than the actual financial report (like an Interim/Quarterly Report or Annual Report). Therefore, the appropriate classification is RPA with high confidence.
2023-05-20 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of a share certificate and the consequent stop transfer of shares until a duplicate certificate is issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and transfer restrictions. The content is an announcement of a specific event related to share certificates and does not contain financial data, management discussion, or report publication. It is not a report or financial statement but a regulatory compliance notification about share certificate status. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-05-20 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation May 2023' and is addressed as an investor presentation pursuant to SEBI regulations. It contains detailed business overview, transformation initiatives, business highlights, financial highlights including income statement data for FY23 and Q4FY23, R&D information, and market/product mix. The document is about 15,000 characters long and contains comprehensive financial and strategic information aimed at investors. It is not a full annual report (10-K), nor an earnings release (ER) which would be shorter and focused on key financial results only. It is not a regulatory filing or certification. The document is clearly an investor presentation as stated in the header and content. Therefore, the correct classification is Investor Presentation (IP).
2023-05-19 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically about Related Party Transactions for the half year ended 31st March 2023. It includes detailed tables and information about related party transactions, which is a regulatory compliance disclosure rather than a full financial report. The document is not an Annual Report, Interim Report, or Earnings Release. It is a regulatory filing made to stock exchanges as per SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS). The document length is substantial (15,000 characters), indicating it is not a mere announcement but a detailed disclosure. Hence, the classification is RNS with high confidence.
2023-05-19 English
Financial Result Updates
Audit Report / Information Classification · 95% confidence The document is a detailed communication from the company to stock exchanges about the outcome of a Board Meeting held on 19.05.2023. It announces the approval of the Audited Financial Statements (Standalone and Consolidated) for the year ended 31 March 2023 and the Financial Results for the quarter and year ended 31 March 2023. The document includes the Independent Auditor's Report on the consolidated annual financial results pursuant to SEBI regulations. The presence of the full auditor's report, detailed opinion, basis for opinion, responsibilities of management and auditors, and other audit-related disclosures indicates this is the actual audit report on the financial results, not merely an announcement or summary. The document length (15,000 characters) and content confirm it is not a brief announcement or certification but a full audit report. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2023
2023-05-19 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.